Skip to search formSkip to main contentSkip to account menu

MYSM1 gene

Known as: KIAA1915, Myb-Like, SWIRM and MPN Domains 1 Gene, Myb like, SWIRM and MPN domains 1 
This gene is involved in both the deubiquitination of histone 2A and transcriptional regulation.
National Institutes of Health

Related topics

Related topics

6 relations
DeubiquitinationHydrolysisMYSM1 protein, humanProteolysis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Neutrophilic Panniculitis in a child with MYSM1 deficiency
Neutrophilic panniculitis (NP) with myelodysplasia has been described in adults but not in children. We report a case of NP… 
2019
2019
MYSM1-AR complex-mediated repression of Akt/c-Raf/GSK-3β signaling impedes castration-resistant prostate cancer growth
Epigenetic alterations that lead to dysregulated gene expression in the progression of castration-resistant prostate cancer (CRPC… 
2019
2019
Mysm1 epigenetically regulates the immunomodulatory function of adipose‐derived stem cells in part by targeting miR‐150
Adipose‐derived stem cells (ASCs) are highly attractive for cell‐based therapies in tissue repair and regeneration because they… 
2018
2018
MYSM1 Is Essential for Maintaining Hematopoietic Stem Cell (HSC) Quiescence and Survival
Background Histone H2A deubiquitinase MYSM1 has recently been shown to be essential for hematopoiesis and hematopoietic stem cell… 
2017
2017
Targeting cistrome and dysregulated transcriptome of post-MPN sAML
Pathogenic mutations in JAK2, MPL or calreticulin associated with activated JAK/STAT3/5 signaling are a common feature in… 
2017
2017
Expression of MYSM1 is associated with tumor progression in colorectal cancer
Colorectal cancer, the third most common cancer in both men and women, has gradually increased in recent years. MYSM1has been… 
2016
2016
MYSM1/miR-150/FLT3 inhibits B1a cell proliferation
The aberrant expansion of B1a cells has been observed in several murine autoimmune disease models; however, the mechanism of such… 
Review
2014
Review
2014
Monitoring Residual Disease in the Ph-Negative Myeloproliferative Neoplasms Post-Allogeneic Stem Cell Transplantation: More Mutations and More Methodologies
The Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) are a group of clonal hematopoietic diseases… 
2013
2013
MYSM1 is mutated in a family with transient transfusion-dependent anemia, mild thrombocytopenia, and low NK- and B-cell counts.
To the editor: Several inherited bone marrow failure syndromes (IBMFSs) have been characterized, such as Fanconi anemia; however… 
2013
2013
TET2 Mutations in Ph-Negative Myeloproliferative Neoplasms: Identification of Three Novel Mutations and Relationship with Clinical and Laboratory Findings
High-throughput DNA sequence analysis was used to screen for TET2 mutations in peripheral blood derived DNA from 97 patients with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)